Citation Impact
Citing Papers
Standardized Low–Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery
2009
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Primary thromboprophylaxis for cancer patients with central venous catheters – a reappraisal of the evidence
2006
Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study
2006
Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery
2006
Parenteral Anticoagulants
2012 Standout
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
2006
Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study
2005
Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
2012
Anticoagulation for patients with cancer and central venous catheters
2011
Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients
2007
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
2011 Standout
Venous thromboembolism in laparoscopic surgery
2003
Contribution of platelets to tumour metastasis
2011 Standout
Economic Evaluation of Enoxaparin vs. Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
2000
Prevention of VTE in Orthopedic Surgery Patients
2012 Standout
Evaluating Meta-analyses in the General Surgical Literature
2005
Therapy for Cancer-Related Thromboembolism
2014
Incidence and Economic Implications of Heparin‐Induced Thrombocytopenia in Medical Patients Receiving Prophylaxis for Venous Thromboembolism
2006
Perioperative Management of Antithrombotic Therapy
2012 Standout
Prophylaxis for Thromboembolism in Hospitalized Medical Patients
2007
Antithrombotic Therapy for VTE Disease
2016 Standout
Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?
2006
Validation of a clinical guideline on prevention of venous thromboembolism in medical inpatients: a before‐and‐after study with systematic ultrasound examination
2004
Utilisation and Safety of Bemiparin, a??Low-Molecular-Weight Heparin, in??Medical Patients
2005
Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score
2004
Deep Vein Thrombosis in Elderly Patients Hospitalized in Subacute Care Facilities
2003
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer
2006
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
2006 Standout
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double‐blind comparison
2007
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
A meta‐analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment
2007
The Effect of Low Molecular Weight Heparin Thromboprophylaxis on Bleeding Complications After Gastric Cancer Surgery
2010
Prevention of fatal pulmonary embolism and mortality in surgical patients
2005
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients
2004
Antithrombotic Therapy for VTE Disease
2012 Standout
Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs
2010
A randomized, double‐blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non‐surgical patients: CERTIFY Study
2010
Executive Summary
2012 Standout
Guidelines on the use and monitoring of heparin
2006
Approach to Outcome Measurement in the Prevention of Thrombosis in Surgical and Medical Patients
2012
Stroke
2008 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Anticoagulation for patients with cancer and central venous catheters
2011
Comparison of Anti–Factor Xa Heparin Activity and Activated Partial Thromboplastin Time in 2,773 Plasma Samples From Unfractionated Heparin–Treated Patients
1997
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
Perioperative Management of Oral Anticoagulation: When and How to Bridge
2006
Low Molecular Weight Heparin and Unfractionated Heparin in Thrombosis Prophylaxis: Meta-Analysis Based on Original Patient Data
2001
Prevention of venous thromboembolism in spinal surgery
2003
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*
2004 Standout
Circadian rhythms and cancer chemotherapy
1995
Venous thromboembolism (VTE) in Europe
2007 Standout
Prevention of Venous Thromboembolism
2004 Standout
Prophylaxis of venous thromboembolism in medical patients
2001
Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention
2007
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Thrombosis and cancer
2012
Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points
2004
Prevention of Venous Thromboembolism
2008 Standout
Cost Effectiveness of Dalteparin for Preventing Venous Thromboembolism in Abdominal Surgery
2005
An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN
2010
Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis
2008
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
2012
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Risk factors for catheter‐related thrombosis (CRT) in cancer patients: a patient‐level data (IPD) meta‐analysis of clinical trials and prospective studies
2010
Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters
2007
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Deep vein thrombosis
2005
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Effectiveness of written guidelines on the appropriateness of thromboprophylaxis prescriptions for medical patients: a prospective randomized study
2006
Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin
2004
Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis
2007
The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison
2007
The Rate of Bleeding Complications After Pharmacologic Deep Venous Thrombosis Prophylaxis
2006
Low-Molecular-Weight Heparin vs Unfractionated Heparin for Perioperative Thromboprophylaxis in Patients With Cancer<subtitle>A Systematic Review and Meta-analysis</subtitle>
2008
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
A Systematic Review of Deep Venous Thrombosis Prophylaxis in Cancer Patients: Implications for Improving Quality
2006
Incidence of Venous Thromboembolism in Hospitalized Patients vs Community Residents
2001
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Diurnal Rhythm in Anticoagulant Effect of Heparin during a Low Dose Constant Rate Infusion
1992
Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients
2003
Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
2004
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function
2007
Economic and Practical Aspects of Thromboprophylaxis With Unfractionated and Low-Molecular-Weight Heparins in Hospitalized Medical Patients
2009
Venous Thromboembolism After Acute Stroke
2001
Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery
2009
Venous thromboprophylaxis in UK medical inpatients
2005
Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)
2014
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
2007
Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery
2005
The management of venous thromboembolism in cancer patients
2007
Prevention of Venous Thromboembolism in Hospitalized Patients With Cancer
2009
Prolonged thromboprophylaxis with Low Molecular Weight heparin for abdominal or pelvic surgery
2009
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis
2005
The Epidemiology of Venous Thromboembolism
2003 Standout
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer
2014
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients
2007
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.
2004
Anticoagulation for people with cancer and central venous catheters
2014
Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)
2004
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2013
Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns.
2002
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients
2005
Economic evaluation of the use of enoxaparin for thromboprophylaxis in acutely ill medical patients
2001
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
2005 Standout
Evidence-Based Surgical Care and the Evolution of Fast-Track Surgery
2008 Standout
Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery
2005
Works of H Decousus being referenced
Fréquence de la maladie thromboembolique en fonction des types de chirurgie
1992
Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta‐analysis
2004
Prevention of Venous Thromboembolism in Internal Medicine with Unfractionated or Low-molecular-weight Heparins: A Meta-analysis of Randomised Clinical Trials
2000
[Biological rhythm and thromboembolic disease. Physiological, epidemiological and pharmacological aspects].
1987
MEASUREMENT OF HEPARIN IN PLASMA: INFLUENCE OF INTER-SUBJECT AND CIRCADIAN VARIABILITY IN HEPARIN SENSITIVITY ACCORDING TO METHOD
1987
Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
2003
Nycthemeral variations of 99Tcm-labelled heparin pharmacokinetic parameters
1985
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
2001